Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Rodinò

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Pharmaceutics|January 28, 2026
Evaluation of the Effect of a Cranberry Formulation in Reducing the Inflammatory State and Improving the Management of Symptoms in Patients with Symptomatic Uncomplicated Diverticular Disease: A Prospective, Open-Label, Single-Arm, Multi-Center, Pilot StudyAntonio Tursi, Stefano Rodinò, Ladislava Sebkova, et al.
Micromachines|July 30, 2025
Artificial Intelligence Control Methodologies for Shape Memory Alloy Actuators: A Systematic Review and Performance AnalysisStefano Rodinò, Giuseppe Rota, Matteo Chiodo, et al.
Minerva Gastroenterology|September 11, 2023
Esophageal rupture after Heimlich maneuver: a case report and literature reviewAntonio Basile, Rocco Spagnuolo, Vincenzo Cosco, et al.
Materials (Basel, Switzerland)|May 20, 2022
Shape Memory Alloy-Polymer Composites: Static and Fatigue Pullout Strength under Thermo-Mechanical LoadingStefano Rodinò, Elio M Curcio, Danilo A Renzo, et al.
Pharmacological Reports : PR|August 19, 2025
Real‑world safety and efficacy of biological agents in inflammatory bowel disease: a one-year post-marketing pharmacovigilance observational study in the Calabria regionAntonio Fabiano, Caterina De Sarro, Domenico Frajia, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|November 23, 2021
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with GolimumabAntonio Tursi, Giammarco Mocci, Walter Elisei, et al.
Current Medical Research and Opinion|June 24, 2020
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern ItalyRoberta Roberti, Luigi Francesco Iannone, Caterina Palleria, et al.
Gut|October 27, 2021
Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort studyAntonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.
The American Journal of Gastroenterology|June 14, 2023
Prevalence and Natural History of Segmental Colitis Associated With DiverticulosisAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
United European Gastroenterology Journal|August 8, 2023
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysisAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Pharmaceutics|January 28, 2026
Evaluation of the Effect of a Cranberry Formulation in Reducing the Inflammatory State and Improving the Management of Symptoms in Patients with Symptomatic Uncomplicated Diverticular Disease: A Prospective, Open-Label, Single-Arm, Multi-Center, Pilot StudyAntonio Tursi, Stefano Rodinò, Ladislava Sebkova, et al.
Micromachines|July 30, 2025
Artificial Intelligence Control Methodologies for Shape Memory Alloy Actuators: A Systematic Review and Performance AnalysisStefano Rodinò, Giuseppe Rota, Matteo Chiodo, et al.
Minerva Gastroenterology|September 11, 2023
Esophageal rupture after Heimlich maneuver: a case report and literature reviewAntonio Basile, Rocco Spagnuolo, Vincenzo Cosco, et al.
Materials (Basel, Switzerland)|May 20, 2022
Shape Memory Alloy-Polymer Composites: Static and Fatigue Pullout Strength under Thermo-Mechanical LoadingStefano Rodinò, Elio M Curcio, Danilo A Renzo, et al.
Pharmacological Reports : PR|August 19, 2025
Real‑world safety and efficacy of biological agents in inflammatory bowel disease: a one-year post-marketing pharmacovigilance observational study in the Calabria regionAntonio Fabiano, Caterina De Sarro, Domenico Frajia, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|November 23, 2021
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with GolimumabAntonio Tursi, Giammarco Mocci, Walter Elisei, et al.
Current Medical Research and Opinion|June 24, 2020
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern ItalyRoberta Roberti, Luigi Francesco Iannone, Caterina Palleria, et al.
Gut|October 27, 2021
Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort studyAntonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.
The American Journal of Gastroenterology|June 14, 2023
Prevalence and Natural History of Segmental Colitis Associated With DiverticulosisAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
United European Gastroenterology Journal|August 8, 2023
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysisAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
Pageof 2